Current Issues of Pharmacy and Medical Sciences

Use of yeasts for prevention and therapy

Current Issues in Pharmacy and Medical Sciences Vol. 26, No. 2, Pages 198-202


Department of Molecular Biology, The John Paul II Catholic University of Lublin, Poland
MeaPharma s.c. Poland
Department of Pharmaceutical Microbiology with the Laboratory of Microbiology Diagnostics, Medical University of Lublin, Poland

DOI: 10.12923/j.2084-980X/26.2/a.17



Yeasts are a rich source of amino acids, proteins, several dietary minerals (e.g. chromium, selenium, zinc, iron, magnesium, cooper, manganese), and the B vitamins, particularly recommended for a vegan or vegetarian diet as well as for young people during maturation. One of the most well-known species of yeasts used in health and wellness is Saccharomyces cerevisiae (the common name is brewer’s yeast). They are often used as a source of B vitamins (B1, B2, B3, B5, B6, B7 and B9). Typically, brewer’s yeast is used as a protein, vitamin and mineral supplement, energy booster, immune enhancer, or vehicle where other compounds can be inserted to create a commercialized health product. The biomass of brewer’s yeast is also considered as an extensive source of bioavailable minerals, particularly chromium and selenium. Chromium is an essential trace mineral, since being part of glucose tolerance factor it helps the body maintain normal blood sugar levels, thereby decreasing appetite (especially for sweet foods). Another yeast species Yarrowia lipolytica contains high levels of many important nutrients, exogenous amino acids, proteins, different minerals, and lipid compounds as mainly unsaturated fatty acids (about 90%). This yeast species is a rich source of nutrients for vegans, vegetarians, athletes and a dietary supplement for people after recovery. Saccharomyces boulardii, a yeast species, has been found to be an effective probiotic. The clinical activity of S. boulardii is especially relevant to antibiotic-associated diarrhoea and recurrent Clostridium difficile intestinal infections. In conclusion, several studies indicate that nutritional yeasts as well as S. boulardii are important products for prophylactic and/or therapeutic purposes.

Files to download


yeast, Saccharomyces cerevisiae, Yarrowia lipolytica, Saccharomyces boulardii, dietary supplements, probiotics


  1. Barbulescu I.D. et al.: Obtaining yeast biomass enriched with copper, zinc and manganese. Romanian Biotech. Lett., 15, 1, 2010.
  2. Blot W.J. et al.: Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J. Natl. Cancer Inst., 15, 85(18), 1993.
  3. Chen J., Raymond K.: Beta-glucans in the treatment of diabetes and associated cardiovascular risks. Vasc. Health Risk Manag., 4(6), 2008.
  4. Clark LC et al.: Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br. J. Urobl., 81, 1998.
  5. Coelho M.A.Z., Amaral P.F.F., Belo I. (2010). Yarrowia lipolytica: an industrial workhorse. In: Méndez-Vilas A. (editors). Current Research, Technology and Education Topics in Applied Microbiology and Microbial Biotechnology. Formatex, p. 930–944.
  6. Combs G.J., Lu J. (2006). Selenium as a cancer preventive agent. In: Hatfield D, Berry M, (editors). Selenium: Its molecular biology and role in human health, 2nd ed. New York: Springer, p. 249-264.
  7. Corrigan A. et al.: Effect of dietary supplementation with a Saccharomyces cerevisiae mannan oligosaccharide on the bacterial community structure of broiler cecal contents. Appl. Environ. Microbiol., 77(18), 2011.
  8. Czerucka D., Piche T., Rampal P.: Review article: yeast as probiotics - Saccharomyces boulardii. Aliment Pharmacol. Ther., 15, 26(6), 2007.
  9. Davies S. et al.: Age-related decreases in chromium levels in 51, 665 hair, sweat, and serum samples from 40,872 patients: implications for the prevention of cardiovascular disease and type II diabetes mellitus. Metabolism.46, 1997.
  10. Dobrzański Z. et al.: The chemical content and feeding value of enriched with chromium, selenium and zinc yeast Saccharomyces cerevisiae. ISAH Mexico, 2003.
  11. Duffield-Lillico A.J., et al.: Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention Cancer Trial. Cancer Epidemiol. Biomark. Prev., 11, 2002.
  12. El-Bayoumy K. et al.: Influence of Selenium-enriched Yeast Supplementation on Biomarkers of Oxidative Damage and Hormone Status in Healthy Adult Males: A Clinical Pilot Study. Cancer Epidemiol, Biomarkers Prev., 11, 2002.
  13. EFSA: Opinion of the scientific panel on additives and products or substances used in animal feed on the safety and efficacy of the product Sel-Plex®2000 as a feed additive according to regulation (EC) No 1831/2003. EFSA Journal., 348, 2006.
  14. Esteban P.F., Vazquez de Aldana C.R., del Rej F.: Cloning and characterization of 1,3-beta-glucanase-encoding genes from non-conventional yeasts. Yeast, 15, 1999.
  15. Guo X.N. et al.: Construction of a Magnesium-Enriched Yeast Strain and Study on Distribution of Magnesium in the Cells. Food Biotechnology, 25, 2011.
  16. Graff S. et al.: Influence of pH conditions on the viability of Saccharomyces boulardii yeast. J. Gen. Appl. Microbiol., 54(4), 2008.
  17. Groenewald M. et al.: Yarrowia lipolytica: Safety assessment of an oleaginous yeast with a great industrial potential. Crit. Rev. Microbiol., 1-20, 2013.
  18. Hu Y. et al.: Selenium-enriched milk proteins and selenium yeast affect selenoprotein activity and expression differently in mouse colon. Br. J. Nutr., 104(1), 2010.
  19. Jacobson G. Dietary selenium and selenized yeast. Suppl AgroFood industry hi-tech. 21, 4, 2010.
  20. Jun L. et al.: Chromium, Selenium, and Zinc Multimineral Enriched Yeast Supplementation Ameliorates Diabetes Symptom in Streptozocin-Induced Mice Biol. Trace Elem. Res., May 146, 2, 2012.
  21. Kamzolowa et. al.: Y. lipolytica activity under thiamine deficiency. Food Technol Biotechnol. 50(4), 2012.
  22. Kazi T.G. et al.: Copper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients. Biol. Trace Elem. Res. 122, 2008.
  23. Kelesidis T., Pothoulakis C.: Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therap. Adv. Gastroenterol., 5(2), 2012.
  24. Khosravi-Boroujeni H. et al.: Favorable effects on metabolic risk factors with daily brewer’s yeast in type 2 diabetic patients with hypercholesterolemia: A semi-experimental study. J. Diabet., 4, 2012.
  25. Król E. et al.: Effects of Chromium Brewer’s Yeast Supplementation on Body Mass, Blood Carbohydrates, and Lipids and Minerals in Type 2 Diabetic Patients. Biol. Trace Elem. Res., 143, 2011.
  26. Lai M.H., Chen Y.Y., Cheng H.H.: Chromium yeast supplementation improves fasting plasma glucose and LDL-cholesterol in streptozotocin-induced diabetic rats. Int. J. Vitam. Nutr. Res., 76, 2006
  27. McFarland L.V. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J. Gastroenterol, 14, 16(18), 2010.
  28. Mertz W. Effects and metabolism of glucose tolerance factor. Nutr Rev. 23, 1975.
  29. Moyad M.A.: Brewer’s/baker’s yeast (Saccharomyces cerevisiae) and preventive medicine: Part II. Urol. Nurs., 28 (1), 2008.
  30. Morris B.W., MacNeil S., Hardisty C.A.: Chromium homeostasis in patients with type II (NIDDM) diabetes. J. Trace Elem. Med. Biol., 13, 1999,.
  31. Murray M.: Biotin: An overlooked essential B vitamin. Am. J. Natural Med., 3, 1996.
  32. Musiał I., Rymowicz W., Kramkowski R.: Characteristic of spray-dried fodder yeast Yarrowia lipolytica. Biotechnologia, 2 (1-2), 2003.
  33. Musiał et al.: Production of Yarrowia lipolytica yeast feed enriched with selenium and chromium. Acta Scientiarum Pol. Biotechnologia, 4 (1-2), 2005.
  34. Offenbacher E., Pi-Sunyer F.: Beneficial effect of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects. Diabetes, 29, 1980.
  35. Pirman T., Oresnik A.: Fe bioavailability from Fe-enriched yeast biomass in growing rats. Animal, 6(2), 2012.
  36. Rahar S. et al: Preparation, characterization, and biological properties of β-glucans. J Adv Pharm Technol Res. 2(2), 2011.
  37. Rajpathak S., et al.: Lower toenail chromium in men with diabetes and cardiovascular disease compared with healthy men. Diab. Care, 27, 2004.
  38. Schrauzer G.N: Selenium yeast: composition, quality, analysis, and safety. Pure Appl Chem., 78, 2006
  39. Sherman L. et al.: Failure of trivalent chromium to improve Hyperglycemia in Diabetes Mellitus. Metabolism, 17, 1968.
  40. Szajewska H., Skórka A., Dylag M.: Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children. Aliment Pharmacol Ther., 1, 25(3), 2007.
  41. Tuman R.W., Bibo J.T., Doisy R.J.: Comparison and effects of natural and synthetic glucose tolerance factor in normal and genetically diabetic mice. Diabetes, 27, 1979.
  42. Vandenplas Y., Brunser O., Szajewska H.: Saccharomyces boulardii in childhood. Eur J. Pediatr., 168(3), 2009.
  43. Weber G, Adamczyk A, Freytag S.: Treatment of acne with a yeast preparation. Fortschr Med., 10, 107(26), 1989.
prev next



July 2020

Mon Tue Wed Thu Fri Sat Sun
    01 02 03 04 05
06 07 08 09 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31